sparfloxacin &#160; ingelesa (Q976559)

Sparfloxacin (ingelesa)

DrugBank ^ingelesa

argitaratze-data

17 azaroa 2015

DrugBank ID ^ingelesa

01208

egitura kimikoa

Sparfloxacin.svg
512 × 322; 6 KB

0 erreferentzia

masa

392,165997 masa atomikoaren unitate

Erreferentzia bat

sparfloxacin (ingelesa)

4 urria 2016

formula kimikoa

C₁₉H₂₂F₂N₄O₃

Erreferentzia bat

sparfloxacin (ingelesa)

19 azaroa 2016

SMILES

CC1CN(CC(N1)C)C2=C(C3=C(C(=C2F)N)C(=O)C(=CN3C4CC4)C(=O)O)F

Erreferentzia bat

sparfloxacin (ingelesa)

19 azaroa 2016

isomeric SMILES ^ingelesa

C[C@@H]1CN(C[C@@H](N1)C)C2=C(C3=C(C(=C2F)N)C(=O)C(=CN3C4CC4)C(=O)O)F

Erreferentzia bat

sparfloxacin (ingelesa)

19 azaroa 2016

defined daily dose ^ingelesa

0,2 gramo

route of administration ^ingelesa

aho emate

Erreferentzia bat

https://www.whocc.no/atc_ddd_index/?code=J01MA09

World Health Organisation international non-proprietary name ^ingelesa

Sparfloxacin (ingelesa)

Erreferentzia bat

ChEMBL ^ingelesa

Sparfloxacin (ingelesa)

19 urtarrila 2016

medical condition treated ^ingelesa

Escherichia coli infectious disease ^ingelesa

Erreferentzia bat

NDF-RT ^ingelesa

NDF-RT ID ^ingelesa

13 abendua 2016

Erreferentzia bat

NDF-RT ^ingelesa

NDF-RT ID ^ingelesa

goiko arnasbideetako infekzio

13 abendua 2016

Erreferentzia bat

NDF-RT ^ingelesa

NDF-RT ID ^ingelesa

13 abendua 2016

Erreferentzia bat

NDF-RT ^ingelesa

NDF-RT ID ^ingelesa

13 abendua 2016

gram-negative bacterial infection ^ingelesa

Erreferentzia bat

NDF-RT ^ingelesa

NDF-RT ID ^ingelesa

13 abendua 2016

infekzio estafilokoziko

Erreferentzia bat

NDF-RT ^ingelesa

NDF-RT ID ^ingelesa

Droga eta Elikagaien Administrazioa

13 abendua 2016

18 abendua 1996

Erreferentzia bat

Inxight: Drugs Database ^ingelesa

2 azaroa 2018

https://drugs.ncats.io/drug/Q90AGA787L

http://www.rxlist.com/zagam-drug/indications-dosage.htm

significant drug interaction ^ingelesa

pentamidine ^ingelesa

Erreferentzia bat

High-priority drug–drug interactions for use in electronic health records ^ingelesa

amiodarone ^ingelesa

Erreferentzia bat

High-priority drug–drug interactions for use in electronic health records ^ingelesa

anagrelide ^ingelesa

Erreferentzia bat

High-priority drug–drug interactions for use in electronic health records ^ingelesa

arsenic trioxide ^ingelesa

Erreferentzia bat

High-priority drug–drug interactions for use in electronic health records ^ingelesa

astemizole ^ingelesa

Erreferentzia bat

High-priority drug–drug interactions for use in electronic health records ^ingelesa

Azitromizina

Erreferentzia bat

High-priority drug–drug interactions for use in electronic health records ^ingelesa

bepridil ^ingelesa

Erreferentzia bat

High-priority drug–drug interactions for use in electronic health records ^ingelesa

klorokina

Erreferentzia bat

High-priority drug–drug interactions for use in electronic health records ^ingelesa

klorpromazina

Erreferentzia bat

High-priority drug–drug interactions for use in electronic health records ^ingelesa

cisapride ^ingelesa

Erreferentzia bat

High-priority drug–drug interactions for use in electronic health records ^ingelesa

(RS)-citalopram ^ingelesa

Erreferentzia bat

High-priority drug–drug interactions for use in electronic health records ^ingelesa

Klaritromizina

Erreferentzia bat

High-priority drug–drug interactions for use in electronic health records ^ingelesa

kokaina

Erreferentzia bat

High-priority drug–drug interactions for use in electronic health records ^ingelesa

disopyramide ^ingelesa

Erreferentzia bat

High-priority drug–drug interactions for use in electronic health records ^ingelesa

dofetilide ^ingelesa

Erreferentzia bat

High-priority drug–drug interactions for use in electronic health records ^ingelesa

domperidone ^ingelesa

Erreferentzia bat

High-priority drug–drug interactions for use in electronic health records ^ingelesa

dronedarone ^ingelesa

Erreferentzia bat

High-priority drug–drug interactions for use in electronic health records ^ingelesa

droperidol ^ingelesa

Erreferentzia bat

High-priority drug–drug interactions for use in electronic health records ^ingelesa

escitalopram ^ingelesa

Erreferentzia bat

High-priority drug–drug interactions for use in electronic health records ^ingelesa

flecainide ^ingelesa

Erreferentzia bat

High-priority drug–drug interactions for use in electronic health records ^ingelesa

halofantrine ^ingelesa

Erreferentzia bat

High-priority drug–drug interactions for use in electronic health records ^ingelesa

haloperidol

Erreferentzia bat

High-priority drug–drug interactions for use in electronic health records ^ingelesa

ibutilide ^ingelesa

Erreferentzia bat

High-priority drug–drug interactions for use in electronic health records ^ingelesa

mesoridazine ^ingelesa

Erreferentzia bat

High-priority drug–drug interactions for use in electronic health records ^ingelesa

Metadona

Erreferentzia bat

High-priority drug–drug interactions for use in electronic health records ^ingelesa

https://www.drugs.com/drug-interactions/methadone-index.html

moxifloxazino

Erreferentzia bat

High-priority drug–drug interactions for use in electronic health records ^ingelesa

Ondansetron

Erreferentzia bat

High-priority drug–drug interactions for use in electronic health records ^ingelesa

pimozide ^ingelesa

Erreferentzia bat

High-priority drug–drug interactions for use in electronic health records ^ingelesa

probucol ^ingelesa

Erreferentzia bat

High-priority drug–drug interactions for use in electronic health records ^ingelesa

procainamide ^ingelesa

Erreferentzia bat

High-priority drug–drug interactions for use in electronic health records ^ingelesa

Kinidina

Erreferentzia bat

High-priority drug–drug interactions for use in electronic health records ^ingelesa

sevoflurane ^ingelesa

Erreferentzia bat

High-priority drug–drug interactions for use in electronic health records ^ingelesa

sotalol ^ingelesa

Erreferentzia bat

High-priority drug–drug interactions for use in electronic health records ^ingelesa

(RS)-sulpiride ^ingelesa

Erreferentzia bat

High-priority drug–drug interactions for use in electronic health records ^ingelesa

terfenadine ^ingelesa

Erreferentzia bat

High-priority drug–drug interactions for use in electronic health records ^ingelesa

tioridazina

Erreferentzia bat

High-priority drug–drug interactions for use in electronic health records ^ingelesa

pregnancy category ^ingelesa

US pregnancy category C ^ingelesa

Erreferentzia bat

iturria

Ingelesezko Wikipedia

subjektuak duen rola

topoisomerase inhibitor ^ingelesa

Erreferentzia bat

NDF-RT ^ingelesa

NDF-RT ID ^ingelesa

5 martxoa 2018

antituberculous drug ^ingelesa

Erreferentzia bat

Medical Subject Headings

MeSH identifikadorea

C061363

15 martxoa 2018

topoisomerase II inhibitor ^ingelesa

Erreferentzia bat

Medical Subject Headings

MeSH identifikadorea

C061363

15 martxoa 2018

‎WHO Aware Classification ^ingelesa

watch ^ingelesa

Erreferentzia bat

InChI=1S/C19H22F2N4O3/c1-8-5-24(6-9(2)23-8)17-13(20)15(22)12-16(14(17)21)25(10-3-4-10)7-11(18(12)26)19(27)28/h7-10,23H,3-6,22H2,1-2H3,(H,27,28)/t8-,9+

2023 ‎AWaRe classification‎ ^ingelesa

osatuta

fluor

0 erreferentzia

karbono

0 erreferentzia

Commons-eko kategoria

Sparfloxacin

0 erreferentzia

Identifikatzaileak

InChI

Erreferentzia bat

sparfloxacin (ingelesa)

19 azaroa 2016

2 erreferentzia

sparfloxacin (ingelesa)

19 azaroa 2016

ChEBI release 2020-09-01 ^ingelesa

CAS zenbakia

110871-86-8

2 erreferentzia

sparfloxacin (ingelesa)

19 azaroa 2016

CAS Common Chemistry ^ingelesa

8 apirila 2021

https://commonchemistry.cas.org/detail?cas_rn=110871-86-8

ChemSpider-ren identifikatzailea

54517

Erreferentzia bat

ChemSpider-ren identifikatzailea

ChemSpider ^ingelesa

54517

Sparfloxacin (ingelesa)

19 azaroa 2016

2 erreferentzia

sparfloxacin (ingelesa)

19 azaroa 2016

InChIKey ^ingelesa

6956367

Erreferentzia bat

InChIKey ^ingelesa

Reaxys registry number ^ingelesa

3658018

Erreferentzia bat

ChEBI ^ingelesa

sparfloxacin (ingelesa)

4 urria 2016

mapping relation type ^ingelesa

exact match ^ingelesa

2 erreferentzia

ChEMBL ^ingelesa

SPARFLOXACIN (ingelesa)

19 azaroa 2016

InChI=1S/C19H22F2N4O3/c1-8-5-24(6-9(2)23-8)17-13(20)15(22)12-16(14(17)21)25(10-3-4-10)7-11(18(12)26)19(27)28/h7-10,23H,3-6,22H2,1-2H3,(H,27,28)/t8-,9+

International Chemical Identifier ^ingelesa

InChI

Erreferentzia bat

ChEMBL ^ingelesa

SPARFLOXACIN (ingelesa)

19 azaroa 2016

SureChEMBL ID ^ingelesa

SCHEMBL41311

2 erreferentzia

based on heuristic ^ingelesa

inferred from InChIKey ^ingelesa

InChIKey ^ingelesa

UniChem compound ID ^ingelesa

205239

Erreferentzia bat

splash10-000j-0922000000-9b26b987caa87b8a13af

UniChem ^ingelesa

SPLASH ^ingelesa

0 erreferentzia

splash10-0007-0098000000-b03088bdb64f116827ad

0 erreferentzia

splash10-052b-0009000000-d679c676e007f977b21f

0 erreferentzia

DSSTox substance ID ^ingelesa

DTXSID9023590

Erreferentzia bat

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard ^ingelesa

DSSTOX compound identifier ^ingelesa

DTXCID50820154

0 erreferentzia

NSC number ^ingelesa

759641

0 erreferentzia

EC zenbakia

629-019-8

Erreferentzia bat

ECHA Substance Infocard database ^ingelesa

ECHA Substance Infocard ID ^ingelesa

100.157.238

27 abendua 2018

5-amino-1-cyclopropyl-7-[(3R,5S)-3,5-dimethylpiperazin-1-yl]-6,8-difluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (ingelesa)

quotation ^ingelesa

CAS no.: 110871-86-8 (ingelesa)

ECHA Substance Infocard ID ^ingelesa

100.157.238

Erreferentzia bat

ECHA Substance Infocard database ^ingelesa

ECHA Substance Infocard ID ^ingelesa

100.157.238

27 abendua 2018

5-amino-1-cyclopropyl-7-[(3R,5S)-3,5-dimethylpiperazin-1-yl]-6,8-difluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (ingelesa)

quotation ^ingelesa

CAS no.: 110871-86-8 (ingelesa)

ATC kodea

J01MA09

Erreferentzia bat

DrugBank ^ingelesa

DrugBank ID ^ingelesa

01208

Sparfloxacin (ingelesa)

argitaratze-data

17 azaroa 2015

Guide to Pharmacology Ligand ID ^ingelesa

10860

Erreferentzia bat

IUPHAR/BPS Guide to PHARMACOLOGY ^ingelesa

5 otsaila 2021

Erreferentzia bat

Medical Subject Headings

MeSH identifikadorea

C061363

14 martxoa 2018

RxNorm ID ^ingelesa

18469

Erreferentzia bat

sparfloxacin (ingelesa)

19 azaroa 2016

DrugBank ID ^ingelesa

DB01208

Erreferentzia bat

InChIKey ^ingelesa

Human Metabolome Database ID ^ingelesa

HMDB0015339

2 erreferentzia

based on heuristic ^ingelesa

inferred from InChIKey ^ingelesa

InChIKey ^ingelesa

2 erreferentzia

sparfloxacin (ingelesa)

19 azaroa 2016

InChIKey ^ingelesa

NDF-RT ID ^ingelesa

Erreferentzia bat

sparfloxacin (ingelesa)

19 azaroa 2016

Probes And Drugs ID ^ingelesa

PD009739

0 erreferentzia

DrugCentral ID ^ingelesa

2466

Erreferentzia bat

KEGG-ren identifikatzailea

UniChem ^ingelesa

C07662

Erreferentzia bat

ChEBI ^ingelesa

sparfloxacin (ingelesa)

4 urria 2016

D00590

Erreferentzia bat

ChEBI ^ingelesa

sparfloxacin (ingelesa)

4 urria 2016

IEDB Epitope ID ^ingelesa

119065

Erreferentzia bat

Immune Epitope Database and Analysis Resource ^ingelesa

IEDB Epitope ID ^ingelesa

119065

1 martxoa 2022

CAB ID ^ingelesa

160598

Erreferentzia bat

CAB Thesaurus ^ingelesa

Freebase-ren identifikatzailea

6 apirila 2020

/m/0fs5kr

Erreferentzia bat

Microsoft Academic identifikatzailea

Freebase Data Dumps ^ingelesa

argitaratze-data

28 urria 2013

0 erreferentzia

Erreferentzia bat

26 urtarrila 2022

https://docs.openalex.org/download-snapshot/snapshot-data-format

UMLS CUI ^ingelesa

C0052585

Erreferentzia bat

sparfloxacin (ingelesa)